Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CRIPT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DCAF16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBM24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SNX21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
U2SURP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF141 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCT6P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
XRCC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ULK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRFIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CIAO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BRWD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAH14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDGFB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SYPL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASB13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STOX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRD5A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on